The calcineurin inhibitor (CNI) market is a vital segment of the immunosuppressant drug industry. Calcineurin inhibitors are primarily used in the prevention and treatment of organ transplant rejection, as well as in autoimmune diseases. The two most widely used CNIs are cyclosporine and tacrolimus. These drugs work by inhibiting the activity of calcineurin, a protein that plays a...